Skip to content

Based on the information gathered, I'll now review the GO-CAM model with ID 56170d5200000012.

Review of GO-CAM Model: gomodel:56170d5200000012

Model Overview

Title: "kctd10 in heart development PMID:24430697"
Taxon: Zebrafish (Danio rerio) - NCBITaxon:7955
Status: Production
Model ID: gomodel:56170d5200000012

Model Components and Structure

This model describes the role of kctd10 in heart development in zebrafish, focusing on its regulation of the transcription factor tbx5a and downstream effects on atrioventricular canal (AVC) development. The model contains the following major activities:

  1. tbx5a (ZFIN:ZDB-GENE-991124-7) with:
  2. DNA-binding transcription factor activity (GO:0003700)
  3. Occurs in nucleus (GO:0005634)
  4. Part of regionalization (GO:0003002)

  5. Positively regulates has2 activity

  6. has2 (ZFIN:ZDB-GENE-020828-1) with:

  7. Molecular function (GO:0003674)

  8. Part of atrioventricular canal development (GO:0036302)

  9. kctd10 (ZFIN:ZDB-GENE-040426-2843) with:

  10. Molecular function (GO:0003674)
  11. Occurs in nucleus (GO:0005634)
  12. Part of regionalization (GO:0003002)

  13. Negatively regulates tbx5a activity

  14. kctd10 (ZFIN:ZDB-GENE-040426-2843) with:

  15. Protein binding (GO:0005515)
  16. Part of molecular function (GO:0003674)
  17. Has part of relationship with kctd10's main activity

Assessment Against GO-CAM Best Practices

1. Biological Content Accuracy

The biological content of the model is well-supported by the literature (PMID:24430697). The paper describes that Kctd10 directly binds to Tbx5a to repress its transcriptional activity, which is crucial for regulating the expression of has2, a key gene in atrioventricular canal development. The paper demonstrates that:

  • Kctd10 deficiency leads to heart malformations
  • In kctd10 mutants, has2 expression expands beyond the AVC region
  • Knockdown of tbx5a rescues the ectopic expression of has2 in kctd10 mutants
  • Kctd10 physically binds to Tbx5a in the nucleus to moderate its activity

The model accurately captures these key findings, showing kctd10 negatively regulates tbx5a, which positively regulates has2, which is involved in AVC development.

2. Representation of Molecular Activities

The model correctly represents:

  • tbx5a as a DNA-binding transcription factor (GO:0003700), which is appropriate based on its UniProt annotation and the paper's findings
  • kctd10 with protein binding activity (GO:0005515), correctly showing its interaction with tbx5a
  • has2 is appropriately shown as being regulated by tbx5a and involved in AVC development

3. Causal Relationships

The causal relationships are correctly represented:

  • kctd10 "directly negatively regulates" (RO:0002630) tbx5a, which accurately captures the direct physical interaction and regulatory relationship described in the paper
  • tbx5a "directly positively regulates" (RO:0002629) has2, which correctly captures that tbx5a acts as a transcriptional activator for has2

These relationships follow the GO-CAM guidelines for representing regulation.

4. Location Information

The model appropriately specifies the nucleus (GO:0005634) as the location for both kctd10 and tbx5a activities, which is consistent with the paper's findings that Kctd10 colocalizes with Tbx5 in the nucleus.

5. Areas for Improvement

While the model is generally well-constructed, I've identified a few areas that could be enhanced:

  1. More Specific Molecular Function for kctd10: The main activity of kctd10 uses a general "molecular function" (GO:0003674) rather than a more specific term. Based on the paper and UniProt entry, a more appropriate term might be "transcription corepressor activity" (GO:0003714) since it directly represses Tbx5a's transcriptional activity.

  2. More Specific Molecular Function for has2: has2 is annotated with the generic molecular function term (GO:0003674). Based on its UniProt entry, a more specific term would be "hyaluronan synthase activity" (GO:0050501).

  3. Expansion of downstream effects: The model could be expanded to show how has2 overexpression leads to excessive hyaluronic acid production, which affects cardiac jelly formation and ultimately heart morphogenesis. The paper clearly describes this mechanism.

  4. Inclusion of heart looping: The paper emphasizes that heart looping failure is a key phenotype in kctd10 mutants. The model could be expanded to show has2's involvement in heart looping (GO:0001947), which is mentioned in the paper.

  5. Regulatory mechanism details: The model could include more detail on how Kctd10 regulates Tbx5a, possibly by including the formation of the Kctd10-Tbx5a complex.

Biological Process Consistency

The model appropriately places the molecular activities within relevant biological processes:

  • Regionalization (GO:0003002) for tbx5a and kctd10 activities
  • Atrioventricular canal development (GO:0036302) for has2 activity

These processes are consistent with the paper's findings about the roles of these genes in heart development.

Final Assessment

This GO-CAM model accurately captures the core regulatory relationship between kctd10, tbx5a, and has2 in zebrafish heart development, particularly in AVC formation. The model correctly represents kctd10 as a negative regulator of tbx5a that acts by direct binding, which in turn controls the expression of has2, a key factor in AVC development.

The model follows GO-CAM best practices for representation of transcription factors and regulatory relationships. The suggested improvements would enhance the specificity and comprehensiveness of the model but do not detract from its current accuracy.

Recommendation: The model is scientifically sound and follows GO-CAM curation practices. It could be enhanced with more specific molecular function terms for kctd10 and has2, and potentially expanded to include downstream effects on cardiac jelly formation and heart morphogenesis.